Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 212
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Dr Ros Watts – Building Communities and Connection
The Psychedelic News Feed: October 27 – November 02, 2025
Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months
CLOSING RECEPTION Travis Gillan’s Revelator
Pα+ Psychedelic Bulletin #212: Delix Posts Early Efficacy Signal; NRx Wants FDA to Ban Competitors’ Ketamine; Cybin Raises $175M
Tryp Therapeutics Reports Clinical Hold on Proposed Phase 2a Study in...
Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product
Open-label study of COMP360 psilocybin therapy for depression in cancer patients...
PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine...
COMPASS Pathways is granted new US patent for crystalline psilocybin
atai Life Sciences Launches atai Impact, a Philanthropic Program to Harness...
Mycrodose Therapeutics and Nova Mentis Announce LOI to Co-Develop Advanced Drug...
Field Trip Health Ltd. Continues Expansion With Psychedelic-Assisted Therapy Centers in...
Psyched Wellness Announces Preliminary Data Showing Potential New Functional Property and...
Cybin Announces Completion of 74 Pre-Clinical Psychedelic Molecule Studies
1
...
211
212
213
...
301
Page 212 of 301